Elisabetta Gerace Selected Research

Elisabetta Gerace Research Topics

Disease

7	Brain Ischemia (Cerebral Ischemia) 10/2021 - 09/2008
6	Brain Injuries (Brain Injury) 01/2021 - 03/2011
5	Infections 02/2024 - 01/2006
4	Ischemia 01/2022 - 09/2008
4	Stroke (Strokes) 01/2018 - 09/2008
3	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2022 - 01/2021
3	Inflammation (Inflammations) 01/2021 - 03/2014
2	Bacterial Infections (Bacterial Infection) 10/2021 - 01/2021
2	Hypoxia (Hypoxemia) 10/2021 - 01/2018
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 11/2017
2	Hypothermia 01/2018 - 06/2012
2	Cryptococcosis 07/2008 - 11/2005
1	Coinfection 02/2024
1	Meningitis 10/2021
1	Ischemic Stroke 10/2021
1	Neuroinflammatory Diseases 10/2021
1	Hyperbilirubinemia 01/2021
1	Gliosis 01/2020
1	Multiple Sclerosis 01/2020
1	Disease Progression 01/2020
1	Brain Infarction 01/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Tuberculosis (Tuberculoses) 01/2018
1	Bovine Tuberculosis 01/2018
1	Infarction (Infarctions) 01/2018
1	Ataxia (Dyssynergia) 11/2017
1	Celiac Disease (Celiac Sprue) 11/2017
1	Epilepsy (Aura) 11/2017
1	Cardiomyopathies (Cardiomyopathy) 11/2016
1	Amyloidosis 11/2016
1	Hyperalgesia 01/2016
1	Dementia (Dementias) 01/2015
1	Cognitive Dysfunction 01/2015
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2015
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2015
1	Asthma (Bronchial Asthma) 03/2014
1	Cough 03/2014
1	Pneumonia (Pneumonitis) 03/2014
1	Airway Remodeling 03/2014
1	Pain (Aches) 01/2013

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2016
4	Oxygen (Dioxygen)IBA 01/2022 - 01/2016
3	BilirubinIBA 01/2022 - 01/2019
3	Neuroprotective AgentsIBA 01/2020 - 01/2009
2	Interleukin-1 (Interleukin 1)IBA 02/2024 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 10/2021
2	gamma-Aminobutyric Acid (GABA)IBA 01/2022 - 01/2009
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2006
2	DexpramipexoleIBA 01/2020 - 01/2018
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2020 - 01/2018
2	3,4-dihydroxyphenylglycolIBA 01/2020 - 09/2008
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2015 - 03/2014
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2015 - 03/2014
2	CytokinesIBA 03/2014 - 07/2008
2	EndocannabinoidsIBA 03/2011 - 01/2009
1	Interleukin-6 (Interleukin 6)IBA 02/2024
1	Interleukin-2 (IL2)IBA 02/2024
1	Interleukin-10 (Interleukin 10)IBA 02/2024
1	Interleukin-12 (IL 12)IBA 02/2024
1	phytobacteriomycin (PBM)IBA 10/2021
1	ChemokinesIBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	Pioglitazone (Actos)FDA Link 01/2021
1	AntioxidantsIBA 01/2021
1	Allopurinol (Remid)FDA LinkGeneric 01/2021
1	VU0092273IBA 01/2020
1	metabotropic glutamate receptor type 1IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	feralIBA 01/2018
1	Memantine (Namenda)FDA Link 01/2018
1	Topiramate (Topamax)FDA LinkGeneric 01/2018
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	Kainic Acid Receptors (Kainate Receptor)IBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	Glutens (Glutelin)IBA 11/2017
1	Kainic Acid (Kainate)IBA 11/2017
1	TransglutaminasesIBA 11/2017
1	gliadin peptide (31-43)IBA 11/2017
1	Prealbumin (Transthyretin)IBA 11/2016
1	Amyloid (Amyloid Fibrils)IBA 11/2016
1	Peptides (Polypeptides)IBA 01/2016
1	AllergensIBA 03/2014
1	Methacholine Chloride (Methacholine)FDA Link 03/2014
1	CollagenIBA 03/2014
1	Hydroxyl RadicalIBA 03/2014
1	Clorgyline (Clorgiline)IBA 01/2013
1	rinvanilIBA 06/2012
1	capsazepineIBA 06/2012
1	TRPV1 receptorIBA 06/2012
1	CannabinoidsIBA 03/2011
1	Glutamic Acid (Glutamate)FDA Link 01/2009
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2009
1	VaccinesIBA 01/2006
1	Polysaccharides (Glycans)IBA 01/2006

Therapy/Procedure

2	Ischemic Postconditioning 01/2020 - 09/2008
2	Therapeutics 01/2018 - 11/2016
1	Lasers (Laser) 10/2021
1	Low-Level Light Therapy (LLLT) 10/2021